For the quarter ending 2026-03-31, HOWL has $58,022K in assets. $45,820K in debts. $46,450K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|
| Cash and cash equivalents | 46,450 | 65,711 | 77,596 | |
| Prepaid expenses and other current assets | 2,284 | 2,462 | 2,843 | |
| Total current assets | 48,734 | 68,173 | 80,439 | |
| Property and equipment, net | 4,290 | 5,088 | 5,490 | |
| Restricted cash and cash equivalents, net of current portion | 0 | 898 | 895 | |
| Operating lease right of use asset | 4,998 | 5,422 | 5,620 | |
| Other assets | 0 | 46 | 122 | |
| Total assets | 58,022 | 79,627 | 92,566 | |
| Accounts payable | 3,569 | 1,078 | 2,774 | |
| Accrued expenses and other current liabilities | 4,515 | 9,021 | 8,543 | |
| Operating lease liability, current | 1,604 | 1,504 | 1,454 | |
| Note payable, net of discount and issuance costs | 28,831 | 6,000 | 2,400 | |
| Total current liabilities | 38,519 | 17,603 | 15,171 | |
| Operating lease liability, net of current portion | 7,216 | 8,140 | 8,587 | |
| Note payable, net of discount, issuance costs, and current portion | - | 21,656 | 24,705 | |
| Derivative liability | 85 | 2,614 | 2,639 | |
| Total liabilities | 45,820 | 50,013 | 51,102 | |
| Common stock, 0.0001 par value, 200,000,000 shares authorized as of march31, 2026 and december31, 2025 48,596,817 shares issued and outstanding as of march31, 2026 and december31, 2025 | 5 | 5 | 5 | |
| Additional paid-in capital | 501,139 | 496,638 | 492,118 | |
| Accumulated deficit | -488,942 | -467,029 | -450,659 | |
| Total stockholders equity | 12,202 | 29,614 | 41,464 | |
| Total liabilities and stockholders equity | 58,022 | 79,627 | 92,566 | |
Werewolf Therapeutics, Inc. (HOWL)
Werewolf Therapeutics, Inc. (HOWL)